PDF
Citation
Print
INTRODUCTION
Migraine is a disabling headache disorder that causes both emotional and sensory disturbances [1]. The comorbidity between migraine and psychiatric disorders is frequently indicated. In particular, migraine sufferers exhibited higher levels of anxiety and stress as well as lower sociability than the healthy individuals [2]. Considering the strong link between the psychosocial and physical aspects of migraine, the improvement of knowledge on potential therapeutic targets is significant in the treatment of this debilitating headache.
The neural mechanism(s) underlying the pathogenesis of migraine is extremely complex and still needs to be addressed in research. In addition to multiple brainstem pain-modulation circuits, a dysfunctional neurolimbic pain network can play a crucial role in the triggering and progression of migraine [3]. There is growing evidence that the amygdala, and more specifically its central (CeA) and basolateral (BLA) areas, may reflect an important part of migraine pathophysiology [4]. Moreover, altered functional connectivity between the amygdala nuclei and visceroceptive cortex has been reported in migraine [4]. A human study found increased functional connectivity of the left amygdala and a decreased level of the right amygdala activity in chronic compared to episodic migraine [5].
Because of its highly lipophilic structure nitroglycerin (NTG) easily passes the blood–brain barrier and lead to nitric oxide production and vasodilation [6]. NTG-induced migraine has been presented as a reliable experimental model of migraine in humans. Oral NTG administration induced migraine-like headache and decreased head pain threshold in humans [7].
Orexin-A is also known as hypocretin-1, is a neuropeptide that is synthesized by a small number of hypothalamic neurons. Upon its binding to the orexin 1 receptor (Orx1R), target cell activation occurs [8]. Due to the projections to the brainstem and limbic regions of the pain matrix, including the amygdala subregions, the orexin neurons are not only involved in sensory processing, but also emotional control of nociceptive reactions. The blockade of Orx1R in the BLA has been shown to induce facilitation of fear extinction consolidation through the activation of BLA outputs to the infralimbic medial prefrontal cortex [9]. Interestingly, orexin connectivity with melanin-concentrating hormone receptor systems in the BLA has been implicated in regulating sociability and mood-related behaviors [10].
The outcomes of previous researches identify an association between migraine and Orx1R [11]. It has been indicated that the activation of Orx1R suppresses trigeminal neural firing induced by dural electrical stimulation in rats [11]. The involvement of the BLA circuitries in migraine headache, and their related emotional disorders, has been supported by different studies. However, little is known about the role of Orx1R expression in the BLA in this regard; therefore, we investigated whether Orx1R signaling in the BLA modulates NTG-induced anxiety and social interaction deficits in rats.
Go to : 
MATERIALS AND METHODS
1. Animals
Adult male Wistar rats (230-260 g body weight) were used in this study. Because of the difficulties in controlling female endocrine balance, only male rats were studied. The rats were housed in a temperature-controlled room (23°C ± 1°C) under a regular 12-hour light/dark cycle with ad libitum access to food and water. All experimental procedures were reviewed and approved by the Ethics Committee of Kerman University of Medical Sciences (IR.KMU.REC1399.267).
2. Drugs
NTG was purchased from Caspian Tamin Pharmaceutical Company (Rasht, Iran). The Orx1R antagonist SB-334867 (Sigma-Aldrich, St. Louis, MO) was dissolved in dimethylsulfoxide (DMSO) and then diluted into artificial cerebrospinal fluid (CSF). The final concentration of DMSO was 0.1%.
3. Surgical procedure
The rats were anesthetized with a ketamine (65 mg/kg/intraperitoneal [i.p.]) and xylazine (10 mg/kg/i.p.) mixture, and fixed on a stereotaxic frame (Stoelting, Wood Dale, IL). A 23-gauge stainless steel guide cannula was implanted bilaterally into the BLA at the following coordinates: 7.8 mm posterior to the bregma, 0.6 mm lateral to the midline, and 5.9 mm ventral to the cortical surface [12]. The animals recovered from the surgical procedure for 1 week before the experiments. At the end of the experiments, using a bilateral injection of 0.5 μL of methylene blue through the cannula, all rats were anatomically inspected for the cannula’s position. Rats with misplaced cannulas were excluded from the analysis and replaced by correct ones. Fig. 1A-C shows the surgical procedure. Fig. 1D shows a typical section of the BLA taken from the Paxinos and Watson rat brain atlas and a representative photograph exhibiting appropriate cannula implantation into the BLA region.
4. Microinjection
The drugs were delivered into the BLA through a 30-gauge stainless steel cannula attached to a 1 μL Hamilton syringe via polyethylene catheter tubing. The tip of the injector protruded 1 mm below the tip of the guide cannula. Each animal received bilateral injections of 1 μL (1 μL/min per side).
5. Experiment groups
In total, 72 rats were used. The rats were randomly divided into 12 groups (6 rats in each group). The simple random sampling method was used. The experimental procures, groups used in each section, and number and the order of behavioral tests are descripted in the flow diagram (Fig. 2). The sample size and number of animal per groups were designated according to the pilot experiments and previous studies in the field in our lab [13,14].
6. Assessment of thermal sensitivity
1) Tail flick test
The tail-flick test was used to assess NTG-induced changes in thermal pain sensitivity. The rats were gently restrained, and radiant heat was applied to the base of the tail. The time taken to withdraw from the heat stimulus was recorded as the withdrawal latency. Tail-flick latency was verified for each rat three times at two-minute intervals, and the average time was recorded. A cutoff time was established at 12 seconds to prevent tissue injury.
2) Hot plate test
The hot plate test was used to measure thermal hyperalgesia. Rats were placed individually on a metal surface maintained at a constant temperature (52°C ± 2°C), and latencies for licking, lifting, or jumping responses were recorded. To prevent tissue damage, a 14 seconds cutoff was used.
7. Assessment of anxiety-like behaviors
1) Elevated plus maze (EPM) test
The maze was 50 cm above the floor and consisted of two open arms that were surrounded by 0.5-cm high transparent Plexiglas ledges and two closed arms of the same size (60 cm) that were enclosed by 40-cm high wooden walls. The four arms met in a 5 cm center square region. Each rat was placed at the junction of the four arms, facing an open arm, and allowed to freely explore the maze for 5 minutes. The number of open arm entries and time spent in open and closed arms were recorded via a video tracking system.
2) Open field (OF) test
The apparatus was constructed of a black-painted wooden box (70 × 70 cm) surrounded by 30 cm high walls. Each rat was placed in the center of the box and allowed to explore for 5 minutes freely. Time spent, and the number of entries into the central zone (covering 40 × 40 cm) were considered in the analysis of anxiety-related behavior.
8. Three-chambered social approach task
The maze consisted of three equal-sized rectangular Plexiglas compartments (20 × 40 × 47 cm), with small openings (5 × 3 cm) in the dividing walls that allow access into each chamber. The compartments could be closed with removable slide doors. Two dome-shaped wire cages (9 cm in diameter, 11 cm in height, with vertical rods spaced 0.5 cm apart) were set in the lateral compartments. A three-step procedure including, habitation, sociability, and social discrimination, was conducted. In the habituation session, each rat was placed in the middle box while the slide doors were open, and allowed to move freely through all three chambers for 5 minutes. In the sociability step, a novel stranger male rat (stranger 1) was confined in one of the wire cages located in the corner of each lateral partition. The wire cup prevented the animal from coming into direct contact and fighting with the other rat. The subject rat was placed in the middle part, with removed doors, and allowed to explore all three chambers for 10 minutes. In the social discrimination trial, a second unfamiliar rat (stranger 2) was placed in the empty dome-shaped wire cage in the opposite compartment. The rat was then allowed to explore the apparatus for 10 minutes with the doors opened. The total time spent in each chamber and the time spent around each wire cage during the two 10 minutes sessions were measured. Besides, a discrimination index (DI) was calculated as follows:
DI = (Time spent near the cage of stranger 1/Time spent near the cage of stranger 1 + stranger 2) × 100%
9. Assessment of NTG-induced spontaneous pain behavior
These behaviors were included: the time of continuous shaking of the head, ipsilateral hind paw facial grooming, and freezing (immobility) behavior characterized by all four paws in contact with the floor without any movement of the vibrissae [15].
10. Light aversion test
The maze consists of a chamber divided into a dark and a light compartment. Each rat was placed in the light chamber first and the behavior of the rat was evaluated over a 10 minutes period. The total time spent in the light and dark compartments was measured to qualify photophobia behavior in NTG-induced migraineurs rats.
11. Statistical analysis
All values are presented as the mean ± standard error of the mean. Data related to migraine-like spontaneous pain behaviors, the hot plate, tail-flick, OF, EPM, and light-dark tests were analyzed with parametric one-way analysis of variance, followed by Tukey’s post-hoc test. However, the data of the three-chambered social approach task was analyzed by the non-parametric Kruskal–Wallis test. Moreover, the Mann–Whitney U-test was performed to further examine differences between experimental groups. P values of less than 0.05 were regarded as statistically significant.
Go to :
RESULTS
1. Thermal hypersensitivity
1) Hot plate test
There were significant differences in hot plate latencies among the studied groups [F (5,35) = 12.413, P < 0.001]. As shown in Fig. 3A, NTG significantly decreased the hot plate reaction time (2.275 ± 0.594) as compared to the control group (5.243 ± 0.592) (P < 0.001). However, intra-BLA administration of SB-334867 at the doses of 10, 20, and 40 nM did not change NTG-induced increased thermal sensitivity in rats (Fig. 3A).
2) Tail flick test
The findings proved significant differences in thermal latency scores in the tail-flick test among the studied groups [F (5,35) = 5.573, P < 0.001]. Treatment with NTG (7.085 ± 0.565) significantly shortened tail-flick latency in comparison to that of the control rats (11.07 ± 0.518) (P < 0.001). However, post-treatment with Orx1R antagonist SB-334867 (10, 20, and 40 nM), did not affect the thermal sensitivity in NTG-treated rats (Fig. 3B).
2. Evaluation of NTG-induced spontaneous migraine-like pain
There were significant differences between groups in head shaking, ipsilateral hind paw facial grooming and freezing behaviors. As shown in Table 1, the time of the head shaking and freezing behavior was significantly increased in rats treated by NTG (P < 0.001). However, the time course of ipsilateral hind paw facial grooming behaviors did not show significant change in rats treated with NTG or NTG plus vehicle as compared to the control group. NTG-induced freezing behavior was exaggerated in rats treated with SB-334867 (40 nM/rat) as compared to the NTG group. Moreover, ipsilateral hind paw facial grooming was significantly increased in rats treated with SB-334867 at 20 (P = 0.038) and 40 nM/rat (P = 0.003) before administration of NTG as compared to the control group. In addition, NTG-induced freezing behavior was significantly increased in rats treated with intra-BLA administration of SB-334867 at all doses (10, 20, and 40 nM/rat) (P < 0.001) (Table 1).
Table 1
Evaluation NTG-induced spontaneous migraine-like headache symptoms between groups
| Group | Spontaneous orofacial pain behavior | ||
|---|---|---|---|
| Head shaking | Ipsilateral hind paw facial grooming | Freezing | |
| Intact | 230.83 ± 32.84 | 10.00 ± 5.16 | 768.33 ± 39.61 |
| NTG | 467.50 ± 53.45** | 39.16 ± 12.93 | 1,958.33 ± 204.53*** |
| NTG + DMSO | 379.16 ± 24.67 | 42.50 ± 8.73 | 1,729.00 ± 107.87*** |
| NTG + SB (10 nM) | 467.50 ± 49.87** | 92.50 ± 9.81*** | 4,240.00 ± 65.01***,### |
| NTG + SB (20 nM) | 594.16 ± 49.60** | 93.33 ± 10.46***,# | 3,778.33 ± 96.89***,### |
| NTG + SB (40 nM) | 770.83 ± 31.07***,## | 110.00 ± 20.08***,## | 4,270.83 ± 140.66***,### |
3. Anxiety-like behaviors
1) EPM test
The groups showed significant differences in the time spent [F (5,35) = 20.065, P < 0.001] and the frequency of visits into the open arms [F (5,35) = 23.023, P < 0.001]. As shown in Fig. 4A, the time spent in the open arms was significantly decreased in rats treated with NTG (56.95 ± 11.950) in comparison with the control group (133.8 ± 13.657) (P < 0.001). Intra-BLA administration of SB-334867 at the dose of 20 nM (15.166 ± 7.77) decreased the time spent in open arms in NTG-treated rats (P = 0.004). Furthermore, administration of NTG significantly decreased the number of entries into the open arms (8.833 ± 1.40) as compared to non-treated control rats (16.833 ± 1.55) (P < 0.001). The effects of NTG were exaggerated by intra-BLA administration of SB-334867 at the doses of 40 nM (P < 0.001) and 20 nM (P = 0.002) (Fig. 4B).
 | Fig. 4The time spent (A) and the number of entries (B) into the open arms of the elevated plus-maze during a 5 minutes test in nitroglycerin (NTG)-treated rats and NTG groups received intra-basolateral amygdala infusion of SB-334867 (10, 20, and 40 nM/rat) (n = 6 per group). Graphs represent the mean ± standard error of the mean. *P < 0.05, **P < 0.01, ***P < 0.001 vs. control group, #P < 0.05 vs. NTG.
|
2) OF test
The groups showed significant differences in the time spent [F (5,35) = 11.425, P < 0.001] and the frequency of entries into the central zone [F (5,35) = 24.162, P < 0.001]. As shown in Fig. 5A, rats treated with NTG (25.283 ± 2.436) spent significantly less time in the central zone of the maze as compared to the control group (59.9 ± 10.302) (P < 0.001). Moreover, the time spent in the central zone was significantly decreased in NTG rats that received intra-BLA administration of SB-334867 at the dose of 40 nM (8.816 ± 1.079) (P = 0.033). In addition, NTG significantly decreased the number of entries into the central zone of the maze (9.166 ± 2.344). However, microinjections of SB-334867, at the different doses, did not alter NTG-related decreased entries into the central zone of the maze (Fig. 5B).
 | Fig. 5The time spent (A) and the number of entries (B) in the central zone of the open filed during a 5 minutes test in nitroglycerin (NTG)-treated rats and NTG groups that received intra-basolateral amygdala infusion of SB-334867 (10, 20, and 40 nM/rat). n = 6 per experimental group. Graphs represent the mean ± standard error of the mean. *P < 0.05, **P < 0.01 vs. control group, #P < 0.05 vs. NTG.
|
4. Light aversion test
A light–dark box was used to assess the NTG-induced photophobia behavior of the rats. The hotophobia behavior was significantly different between the groups [F (5,35) = 36.320, P < 0.001]. As shown in Fig. 6, time spent in the dark chamber was significantly increased in rats treated with NTG or NTG + DMSO as compared to control group (P < 0.001). Intra-BLA administration of SB-334867 (20 and 40 nM/rat) significantly increased NTG-induced increases in time spent in the dark chamber of the box (P < 0.001).
5. Social interaction task
In the sociability test, as shown in Fig. 7A, the time that NTG rats spent in the compartment with an unfamiliar rat (stranger 1) was significantly decreased compared to that of the control group (P = 0.015). Moreover, intra-BLA infusion of SB-334867 (20 and 40 nM/rat) significantly increased the effects of NTG (P < 0.001). Besides, the NTG group and NTG groups post-treated with SB-334867 (20 and 40 nM/rat) spent a significantly shorter time around the wire cage containing stranger 1 than that of the control rats (P < 0.001) (Fig. 7C). The social DI and the time that NTG treated rats spent in the chamber containing stranger 2 were significantly decreased compared to the intact animals (P = 0.026). The NTG effects were strengthened significantly following intra-BLA administration of SB-334867 at 10 (P = 0.041) 20 (P = 0.009) and 40 nM/rat (P = 0.004) (Fig. 7B, D).
 | Fig. 7Sociability in the three-chambered task. The time spent in the chamber containing stranger 1 (A) and stranger 2 (B), and the time spent in close proximity with the cage containing stranger 1 (C). Social discrimination (D). n = 6 per experimental group. Bar graphs represent mean ± standard error of the mean. NTG: nitroglycerin, SB: SB-334867. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. control, #P < 0.05 NTG and NTG plus vehicle.
|
Go to :
DISCUSSION
In the present study, we showed that the inactivation of Orx1R in the BLA of rats suffering NTG- induced migraine increased photophobia, anxiety-like behavior, and social interaction deficits. In addition, Orx1R antagonism was associated with increases in spontaneous migraine–like headache behaviors in NTG-treated rats. Besides, NTG increased thermal pain sensitivity in both the tail-flick and hot plate tests. However, pharmacological blockade of the Orx1R did not affect the NTG-induced thermal hyperalgesia.
Previous data strongly suggested that NTG evokes sensory hypersensitivity associated with migraine [16,17]. Chronic administration of NTG causes neuronal hyperactivity in the trigeminal and midbrain nociceptive pathways [18], which can induce central sensitization by over-expression of various pain signaling mediators [19]. Suppression of NTG-evoked pain sensitivity in rodents given anti-migraine medicines provides support for the validity of the NTG-induced model of migraine [20].
Somatosensory hypersensitivity and reduced cutaneous pain thresholds have been distinguished as clinical symptoms associated with migraine headache [21]. The majority of migraineurs have been shown physiologic evidence for thermal and mechanical cutaneous stimuli during the headache [22,23]. For example, it has been indicated that interictal cutaneous pain thresholds are lower in episodic and chronic migraine patients compared to non-migraine controls [24]. Specially, NTG-induced migraine has been associated with a significant heat pain threshold reduction in humans [7]. So, here, thermal hyperalgesia was evaluated as a relevant indication for migraine.
The data showed that Orx1R antagonism in the BLA enhanced NTG-induced spontaneous orofacial pain. In specific regard to NTG-related migraine pain, activation of Orx1R in the ventrolateral preaqudactal gray matter has increased spontaneous pain behaviors in rats. In a clinical study, patients with episodic migraine showed an increase in orexin-A concentration as measured in the CSF. The hypothalamic orexinergic neurons are densely projected to other brain systems involved in migraine pathophysiology, especially limbic structures and the trigeminal cervical complex of the brainstem, implicated in the transmission of the trigeminal nociceptive to higher thalamic and cortical areas. It shows the importance of orexinergic systems to control attack susceptibility and modulation of affective and emotional symptoms relevant to migraine.
Following the blockade of Orx1R in the BLA, NTG-induced anxiety-like behavior was overstated in both the EPM and OF tasks. This finding suggests the role of endogenous orexin signaling within the BLA in modulating anxiety in migraine. Also, dysfunction of the orexinergic system has been shown to be related to pathological anxiety states [25]. Interestingly, abnormally elevated levels of orexin have been found in the cerebrospinal fluid of patients with migraine or panic disorder [26,27]. It has also been indicated that intra-amygdala infusion of SB-334867 enhances fear extinction associated with increased neuronal activity in the BLA and infralimbic cortex [28].
Although the mechanism(s) by which the Orx1R system within the BLA modulates NTG-induced anxiety is not entirely clear, it appears to act by receptor activation and subsequent alterations in intracellular targets. The Orx1R activation evokes a wide range of intracellular signaling cascades, including cAMP-dependent protein kinase A (cAMP-PKA) and the extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK) [29]. The crucial roles of such pathways in controlling anxiety and affective responsiveness have been suggested in previous studies [30,31].
Intra-BLA administration of PKA agonist decreased the anxiogenic, social defeat stress-induced behaviors in both the EPM and OF tests. Moreover, the antidepressant clomipramine reduced anxiety and up-regulated PKA levels in the BLA [32]. It has been indicated that the activation of the ERK/MAPK signaling pathway is necessary for the acquisition of conditioned fear [33], whereas, the activation of ERK2 in the BLA increased anxiety-like behaviors in stressed rats [34]. Altogether, these results suggest the potential dual effects (excitatory or inhibitory) of the orexin system and its downstream targets on anxiety disorders. So, it is not possible to assume that hyperactivity of the orexin system in the BLA acts as functional compensation to preserve a normal physiological state through the masking of anxiogenic-like effects induced by NTG. Further studies may then be needed to identify the interventional effects of Orx1R signaling on migraine-related anxiety.
We also found that bilateral inhibition of Orx1R in the BLA enhanced social interaction dysfunction in NTG-treated rats. In line with our observation, Abbas et al. [35], also indicated impaired sociability and social novelty preferences in Orx1R knockout mice. Moreover, selective ablation of orexin neurons in orexin/ataxin-3 transgenic mice has been associated with deficits in long-term social memory. Such effects were suppressed by intra-nasal administration of exogenous orexin A [36]. Interestingly, a human study showed that the levels of orexin A in the amygdala are maximal during positive emotion, social interaction, and anger [37]. On the other hand, the activation of orexin signaling during social defeat stress decreased subsequent social interaction and recognition memory in rats [38]. Totally, the data support an association between the orexin system and sociability behaviors.
The orexinergic neurons of the BLA express interactions with a number of neuronal populations involved in the regulation of social and emotional competence. The balance between excitatory and inhibitory transmission in the BLA is important for maintaining normal neuronal activity [39]. It is, therefore, likely that inactivation of Orx1R signaling in the BLA causes functional alterations in other receptor systems. Such an idea can be supported by the studies using genetic or pharmacological inhibition methodologies that demonstrate the interaction of Orx1R with various brain neurotransmitter systems including gamma aminobutyric acid, glutamate, and cannabinoid receptors [40-42]. However, challenges and open issues regarding the interplay between Orx1R and other receptor systems in the BLA need to be further investigated.
Specifically, our data indicated that intra-BLA Orx1R blockade had no significant effect on NTG-induced nociceptive hypersensitivity. There is no previous report that supports a possible role of Orx1R in the BLA in central sensory processing of pain signals. However, the association between sensory processing of migraine and Orx1R has been demonstrated in previous studies. Holland et al. [11], using a rat model with electrical stimulation of dura mater, showed that intravenous administration of orexin A suppressed trigeminal neuronal firing, and this effect was prevented by SB-334867, a selective Orx1R antagonist. Nonetheless, it has been indicated that chronic daily oral administration of filorexant, a dual orexin receptor antagonist, is not adequate for migraine prophylaxis. Such controversial results yielded by different studies may indicate the site-specific effects of Orx1R on the modulation of migraine pain.
The BLA has been shown to play a fundamental role in the processing of negative emotions and pain-related memories [43,44]. However, the involvement of the BLA in sensory input modulation is even more complicated by incorporating the CeA and prefrontal cortical circuitries [43,45]. Based on the findings in this study, it seems likely that the ability of Orx1R to modulate comorbid psychiatric disorders in patients with migraine is superior to its effect on sensory processing.
Accumulating evidence support the critical role of orexin system in the modulation of various types of pain including migraine [13]. In this study, unexpectedly, inactivation of Orx1R in the BLA did not change pain sensitivity (thermal) in the tail flick and hot plate test. None-the-less, SB-334867 administration could increase NTG-induced migraine-like spontaneous pain behavior. No change in thermal pain sensitivity can be somewhat related to methods used to measure hyperalgesia, SB-334867 doses, and the injection site in the BLA, which is a nonspecific brain structure for transmission and processing of nociceptive signals. In any case, additional studies are still required to determine the distinct roles of Orx1R within the BLA on pain sensitivity.
In this study, a limitation was that we evaluated the migraine model in only male rats. Based on epidemiological studies, there are sex-related differences in migraine phenotypes [46,47]. Neuroimaging studies in patients suffering from migraine have revealed anatomical and functional differences in regional brain activity between males and females [48,49]. In addition, puberty-related changes in syntheses and concentrations of sex hormones, mostly estrogen, play an important role in the frequency and severity of migraine headaches [47]. So, complementary research on females would be helpful in explaining the potential difference between the two sexes in vulnerability to NTG-induced migraine headache. Another limitation was that we evaluated NTG-related allodynia with only thermal stimuli. Allodynia in migraine is thermal, mechanical, dynamic, and mechanical static. Therefore, in this study, other components of allodynia were not evaluated.
Taken together, these findings suggest the potential value of orexinergic system of the BLA in the regulation of NTG-induced anxiety and social interaction deficits in rats. However, the blockade of Orx1R did not affect pain sensitivity, suggesting that Orx1R may play a more critical role in the modulation of comorbid psychiatric disorders rather than in sensory processing in patients with migraine.
Go to :
XML Download